Serial MR spectroscopy in relapsing reversible posterior leukoencephalopathy syndrome

Neurologist

Volumn 15, Issue 6, 2009, Pages 338-341

  Lee, Seo Young ^a   Kim, Sung Hun ^a   Lee, Seung Hwan ^a   Baek, Hyun Jeong ^a   Shon, Hong Seok ^a   Kim, Sam Soo ^a  

^a Kangwon National University   (South Korea)

Author keywords

Diffusion weighted imaging (DWI); Magnetic resonance spectroscopy (MRS); Reversible posterior leukoencephalopathy syndrome (RPLS)

Indexed keywords

N ACETYLASPARTIC ACID;

ADULT; ARTICLE; CASE REPORT; CONVALESCENCE; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; HUMAN; HYPERTENSION ENCEPHALOPATHY; MALE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME; PRIORITY JOURNAL;

ADULT; ASPARTIC ACID; CREATINE; DIFFUSION MAGNETIC RESONANCE IMAGING; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; PHOSPHOCREATINE; POSTERIOR LEUKOENCEPHALOPATHY SYNDROME;

EID: 73349127086     PISSN: 10747931     EISSN: None     Source Type: Journal    
DOI: 10.1097/NRL.0b013e3181914af6     Document Type: Article

References (15)

1. Bartynski WS, Boardman JF. Distinct imaging patterns and lesion distribution in posterior reversible encephalopathy syndrome. Am J Neuroradiol. 2007; 28:1320-1327.
2. McKinney AM, Short J, Truwit CL, et al. Posterior reversible encephalopathy syndrome: incidence of atypical regions of involvement and imaging findings. AJR Am J Roentgenol. 2007;189:904-912.
3. Hinchey J, Chaves C, Appignani B, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med. 1996;334:494-500.
4. Eichler FS, Wang P, Wityk RJ, et al. Diffuse metabolic abnormalities in reversible posterior leukoencephalopathy syndrome. Am J Neuroradiol. 2002; 23:833-837.
5. Kwon S, Koo J, Lee S. Clinical spectrum of reversible posterior leukoencephalopathy syndrome. Pediatr Neurol. 2001;24:361-364.
6. Russell MT, Nassif AS, Cacayorin ED, et al. Gemcitabine-associated posterior reversible encephalopathy syndrome: MR imaging and MR spectroscopy findings. Magn Reson Imaging. 2001;19:129-132.
7. Sengar AR, Gupta RK, Dhanuka AK, et al. MR imaging, MR angiography, and MR spectroscopy of the brain in eclampsia. Am J Neuroradiol. 1997;18: 1485-1490.
8. Pavlakis SG, Frank Y, Kalina P, et al. Occipital-parietal encephalopathy: a new name for an old syndrome. Pediatr Neurol. 1997;16:145-148.
9. Burtscher IM, Holtås S. Proton MR spectroscopy in clinical routine. J Magn Reson Imaging. 2001;13:560-567.
10. De Stefano N, Filippi M, Miller D, et al. Guidelines for using proton MR spectroscopy in multicenter clinical MS studies. Neurology. 2007;69:1942-1952.
11. Barker PB, Lee RR, McArthur JC. AIDS dementia complex: evaluation with proton MR spectroscopic imaging. Radiology. 1995;195:58-64.
12. Cakmakci H, Kurul S, Iscan A, et al. Proton magnetic resonance spectroscopy in three subacute sclerosing panencephalitis patients: correlation with clinical status. Childs Nerv Syst. 2004;20:216-220.
13. Wellard RM, Briellmann RS, Wilson JC, et al. Longitudinal study of MRS metabolites in Rasmussen encephalitis. Brain. 2004;127(pt 6):1302-1312.
14. Cecil KM, Jones BV, Williams S, et al. CT, MRI, and MRS of Epstein-Barr virus infection: case report. Neuroradiology. 2000;42:619-622.
15. Fuller RA, Westmoreland SV, Ratai E, et al. A prospective longitudinal in vivo 1H MR spectroscopy study of the SIV/macaque model of neuroAIDS. BMC Neurosci. 2004;5:10.